Skip to main content

Catherine Mackey

Catherine Mackey has been elected to Sequenom's board, where she will serve on the audit and nominating, and corporate governance committees. Mackey is CEO of Cyprus Therapeutics and was previously senior VP of worldwide R&D at Pfizer. Before that, she was VP of strategic alliances at the pharma firm.

She is a special advisor to Fortis Advisors and is a director at Rady Children's Hospital. Mackey also chairs the board of Cour Pharmaceutical Development and is on the boards of Evolve Biosystems and Viventia Bio.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.